Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Cited by (930)

Items 101–200 of 930

1. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
   Chris J. Kapelios, Jonathan R. Murrow, Thomas Georg Nührenberg, Maria N. Montoro Lopez · 2019 · Heart Failure Reviews
2. Atrial Functional Mitral Regurgitation – Prevalence, Characteristics and Outcomes from the National Echo Database of Australia
   Avalon Moonen, Martin K C Ng, David A. Playford, Geoff A. Strange, Gregory Michael Scalia, David Stephen Celermajer · 2022 · Open Heart
3. Iron Deficiency in Heart Failure: Screening, Prevalence, Incidence and Outcome Data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements Collaborative Project
   Felix Lindberg, Lars H. Lund, Lina Benson, Cecilia Marianne Linde, Nicola Orsini, Juan Jesús Carrero, Gianluigi Savarese · 2023 · European Journal of Heart Failure
4. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction
   Pedro Moliner, Josep Lupón, Jaume Barallat, Marta de Antonio, Mar Domingo, Julio E. Núñez, Elisabet Zamora, Amparo Galán, Javier Santesmases, Cruz Pastor et al. · 2018 · International Journal of Cardiology
5. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)
   Susan Stienen, João Pedro Ferreira, Masatake Kobayashi, Grégoire Preud’homme, Daniela Dobre, Jean‐Loup Machu, Kévin Duarte, Emmanuel Bresso, Marie‐Dominique Devignes, Natalia López‐Andrés et al. · 2020 · Biomarkers
6. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
   Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina Andrea Schütt et al. · 2024 · Clinical Research in Cardiology
7. Trends in Heart Failure Mortality in Sweden Between 1997 and 2022
   Felix Lindberg, Lina Benson, Ulf Dahlström, Lars H Lund, Gianluigi Savarese · 2024 · European Journal of Heart Failure
8. Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands
   CHECK-HF investigators, Jasper Jan Brugts, Gerard C.M. Linssen, Arno Wilhelmus Hoes, Hans‐Peter Brunner‐La Rocca · 2018 · Netherlands Heart Journal
9. Heart Failure with Mid-Range Ejection Fraction and How to Treat It
   Yu. M. Lopatin · 2018 · Cardiac failure review
10. The Prognosis of Mid-Range Ejection Fraction Heart Failure: A Systematic Review and Meta-Analysis
    Saif Altaie, Wissam I. Khalife · 2018 · ESC Heart Failure
11. Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: Design and Accreditation Document
    Petar M Seferovic, Massimo Francesco Piepoli, Yu. M. Lopatin, Ewa Anita Jankowska, Marija M. Polovina, Manuel P. Anguita-Sánchez, Stefan Störk, Mitja Lainščak, Davor Miličić, Ivan Milinković et al. · 2020 · European Journal of Heart Failure
12. Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
    Jun Hwan Cho, Won-Seok Choe, Hyun‐Jai Cho, Hae‐Young Lee, Jieun Jang, Sang Eun Lee, Jin‐Oh Choi, Eun‐Seok Jeon, Min‐Seok Kim, Kyung‐Kuk Hwang et al. · 2018 · Circulation Journal
13. Sex, Drugs, and Heart Failure: A Sex-Sensitive Review of the Evidence Base Behind Current Heart Failure Clinical Guidelines
    Anna Levinsson, Marie‐Pierre Dubé, Jean‐Claude Tardif, Simon de Denus · 2018 · ESC Heart Failure
14. Validation and Recalibration of Seattle Heart Failure Model in Japanese Acute Heart Failure Patients
    Yasuyuki Shiraishi, Shun Kohsaka, Toshiyuki Nagai, Ayumi Goda, Atsushi Mizuno, Yuji Nagatomo, Yasumori Sujino, Ryoma Fukuoka, Mitsuaki Sawano, Takashi Kohno et al. · 2018 · Journal of Cardiac Failure
15. Frailty in patients with heart failure
    Cristiana Vitale, Izabella Uchmanowicz · 2019 · European Heart Journal Supplements
16. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
    Massimo Francesco Piepoli, Marianna Adamo, Andrea Barison, Reinaldo B. Bestetti, Jan Biegus, Michael Böhm, Javed Butler, Jonathan Rhys Carapetis, Claudio Ceconi, Ovidiu Dragomir Chioncel et al. · 2021 · European Journal of Preventive Cardiology
17. Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study
    on behalf of the PREDICTOR Study Group, Giulia Cesaroni, Gian Francesco Mureddu, Nera Agabiti, Flávia Mayer, Massimo Stafoggia, Francesco Forastiere, Roberto Latini, Serge Masson, Marina Davoli et al. · 2021 · BMC Public Health
18. The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study
    Shintaro Kasahara, Yasuhiko Sakata, Kotaro Nochioka, Wan Ting Tay, Brian Lee Claggett, Ruri Abe, Takuya Oikawa, Masayuki Sato, Hajime Aoyanagi, Masanobu Miura et al. · 2018 · International Journal of Cardiology
19. Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure
    Matteo Pagnesi, Marianna Adamo, Iziah Edwin Sama, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Riccardo Maria Inciardi, Chim Choy Lang, Carlo Lombardi et al. · 2022 · Clinical Research in Cardiology
20. Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients With Heart Failure
    Pierpaolo Pellicori, Alessia Urbinati, Kuldeep Kaur, Jufen Zhang, Parin Purvin Shah, Syed Kazmi, Alessandro Capucci, John G.F. Cleland, Andrew L. Clark · 2019 · The American Journal of Cardiology
21. Heart Failure With Mid-range Ejection Fraction
    Pratyaksh K. Srivastava, Jeffrey J. Hsu, Boback Ziaeian, Gregg C. Fonarow · 2020 · Current Heart Failure Reports
22. Heart failure with preserved ejection fraction: Similarities and differences between women and men
    Carl J. Pepine, C. Noel Bairey Merz, Stephanie C. El Hajj, Keith C. Ferdinand, Michèle A. Hamilton, Kathryn J. Lindley, Michael Douglas Nelson, Odayme Quesada, NANETTE KASS WENGER, Jerome L. Fleg · 2020 · International Journal of Cardiology
23. Cause-Specific Death in Heart Failure Across the Ejection Fraction Spectrum: A Comprehensive Assessment of Over 100 000 Patients in the Swedish Heart Failure Registry
    Camilla Settergren, Lina Benson, Angiza Shahim, Ulf Dahlström, Tonje Thorvaldsen, Gianluigi Savarese, Lars H. Lund, Bahira Shahim · 2024 · European Journal of Heart Failure
24. Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
    Marco Metra, Matteo Pagnesi, Brian Lee Claggett, Rafael Díaz, Gary Michael Felker, John J.V. McMurray, Scott David Solomon, Diana Bonderman, James Chen-Tson Fang, Cândida Fonseca et al. · 2022 · European Heart Journal
25. Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    John W. Ostrominski, Muthiah Vaduganathan, Brian Lee Claggett, Rudolf A. de Boer, Akshay Suvas Desai, Dan Dobreanu, Adrian F. Hernandez, Silvio E. Inzucchi, Pardeep S. Jhund, Mikhail Kosiborod et al. · 2022 · European Journal of Heart Failure
26. Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry
    Bahira Shahim, Angiza Shahim, Marianna Adamo, Ovidiu Chioncel, Lina Benson, María G. Crespo‐Leiro, Stefan D. Anker, Andrew J.S. Coats, Gerasimos S Filippatos, Mitja Lainščak et al. · 2023 · European Journal of Heart Failure
27. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction
    Andrija S. Pavlovic, Marija M. Polovina, Arsen D. Ristić, Jelena P. Seferović, Ivana Veljić, Dejan S. Simeunović, Ivan Milinković, Gordana Krljanać, Milika Ašanin, Irena Ostric et al. · 2018 · European Journal of Preventive Cardiology
28. Heart failure with reduced ejection fraction
    Antonio Nicola Cannata, Maria Generosa Crespo-Leiro, Daniel I. Bromage, Frank Ruschitzka, Theresa A. McDonagh · 2025 · The Lancet
29. 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway
    Patrick T. O’Gara, JoAnn M. Lindenfeld, Rebecca Tung Hahn, Megan Joseph, Omar K. Khalique, Prateeti Khazanie, Dharam J. Kumbhani, Robert Lee Page II, Kristen K. Patton, Vinod H. Thourani · 2025 · Journal of the American College of Cardiology
30. Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
    Xuefeng Chen, Qian Yang, Wenlou Bai, Wenjing Yao, Litian Liu, Yuanyuan Xing, Cunliang Meng, Peng Qi, Yi Dang, Xiaoyong Qi · 2022 · Frontiers in Pharmacology
31. Medical Therapy for Functional Mitral Regurgitation
    Assi Milwidsky, Sheetal Vasundara Mathai, Yan Topilsky, Ulrich P. Jorde · 2022 · Circulation Heart Failure
32. Detailed Assessment of the “I Need Help” Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry
    Matteo Pagnesi, Daniele Ghiraldin, Enrico Vizzardi, Mauro Chiarito, Davide Stolfo, Luca Baldetti, Marianna Adamo, Carlo Lombardi, Riccardo Maria Inciardi, Daniela Tomasoni et al. · 2023 · Circulation Heart Failure
33. INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
    Ayman Samman‐Tahhan, Jeffrey Hedley, Andrew A. McCue, Jonathan B. Bjork, Vasiliki V. Georgiopoulou, Alanna A. Morris, Javed Butler, Andreas P. Kalogeropoulos · 2018 · JACC Heart Failure
34. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
    Hanna Fröhlich, Niklas Rosenfeld, Tobias Täger, Kevin M Goode, Syed Kazmi, Torstein Hole, Hugo Albert Katus, Dan Atar, John G.F. Cleland, Stefan Agewall et al. · 2019 · Heart
35. Gender differences in the impact of health literacy on hospital readmission among older heart failure patients: A prospective cohort study
    Youn‐Jung Son, Mi Hwa Won · 2020 · Journal of Advanced Nursing
36. Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
    Giuseppe Ambrosio, Mª Generosa Crespo Leiro, Lars H. Lund, Stefano Coiro, Andrea Cardona, Gerasimos S Filippatos, Roberto Ferrari, Massimo Francesco Piepoli, Andrew J.S. Coats, Stefan D. Anker et al. · 2021 · European Journal of Internal Medicine
37. Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
    Oksana M. Drapkina, Olga N. Dzhioeva · 2020 · CARDIOVASCULAR THERAPY AND PREVENTION
38. The global epidemiology of heart failure: a comprehensive and contemporary review
    Valeria Valente, Renzo Laborante, Amr M. Abdin, Peter Moritz Becher, M L Mitja Lainscak, Marija M. Polovina, Cristina Gavina, Gianluigi Savarese · 2026 · European Journal of Heart Failure
39. Is Heart Failure Misdiagnosed in Hospitalized Patients with Preserved Ejection Fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
    Agnieszka Kapłon‐Cieślicka, Cécile Laroche, María G. Crespo‐Leiro, Andrew J.S. Coats, Stefan D. Anker, Gerasimos S Filippatos, Aldo Pietro Maggioni, Camilla Hage, Antonio Lara‐Padrón, Alessandro Fucili et al. · 2020 · ESC Heart Failure
40. Hypertensive Heart Disease: A Narrative Review Series—Part 2: Macrostructural and Functional Abnormalities
    Valeriya Danilovna Nemtsova, Thilo Burkard, Annina Salome Vischer · 2023 · Journal of Clinical Medicine
41. Multi-Ethnic Comparisons of Diabetes in Heart Failure with Reduced Ejection Fraction: Insights from the HF-ACTION trial and the ASIAN-HF Registry
    Lauren Beth Cooper, Jonathan Jiunn Liang Yap, Wan Ting Tay, Tiew‐Hwa Katherine Teng, Michael Ross MacDonald, Inder S. Anand, Abhinav Sharma, Christopher M. O’Connor, William E. Kraus, Robert John Mentz et al. · 2018 · European Journal of Heart Failure
42. Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure
    Gorazd Košir, Borut Jug, Marko Novaković, Mojca Božič Mijovski, Juš Kšela · 2019 · Disease Markers
43. Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF
    Mark E. Pepin, Philipp J.M. Konrad, Sumra Nazir, Farhad Bazgir, Christoph Maack, Alexander Georg Nickel, Joshua Gorham, Mathias Hohl, Friederike C. Schreiter, Matthias Dewenter et al. · 2025 · Circulation Research
44. Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
    Edouard L. Fu, Elisabetta Patorno, Brendan M. Everett, Muthiah Vaduganathan, Scott David Solomon, Raisa Levin, Sebastian Schneeweiß, Rishi J. Desai · 2023 · European Heart Journal
45. Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry
    Jasper Tromp, Justin Adrian Ezekowitz, Wouter Ouwerkerk, Chanchal Chandramouli, Kai Hang Yiu, Christiane E. Angermann, Ulf Dahlström, Georg Ertl, Mahmoud Hassanein, Sergio V. Perrone et al. · 2023 · JACC Heart Failure
46. The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure
    Simone Pasquale Crispino, Andrea Segreti, Vincenzo Nafisio, Daniele Valente, Filippo Crisci, Aurora Ferro, Ilaria Cavallari, Annunziata Nusca, Gian Paolo Ussia, Francesco Grigioni · 2025 · Biomedicines
47. Value of the CHA2DS2-VASc Score for Predicting Outcome in Patients with Heart Failure
    Mony Shuvy, Donna R. Zwas, Andre Keren, Israel Gotsman · 2020 · ESC Heart Failure
48. Arrhythmic syncope: From diagnosis to management
    Jaume Francisco Pascual, Pablo Jordán, Jesús Rodríguez Silva, Nuria Rivas‐Gándara · 2023 · World Journal of Cardiology
49. Heart Failure Care in the Central and Eastern Europe and Baltic Region: Status, Barriers, and Routes to Improvement
    Ovidiu Dragomir Chioncel, Jelena Čelutkienė, Jan Bělohlávek, Ginta Kamzola, Mitja Lainščak, Béla Péter Merkely, Davor Miličić, Jadwiga Nessler, Arsen D. Ristić, Lidia Sawiełajc et al. · 2024 · ESC Heart Failure
50. PHARMacy-Based Interdisciplinary Program for Patients with Chronic Heart Failure (Pharm-Chf): Rationale and Design of a Randomized Controlled Trial, and Results of the Pilot Study
    Ulrich Laufs, Nina Griese‐Mammen, Katrin Krueger, Angelika Wachter, Stefan D. Anker, Friedrich Koehler, Volker Rettig‐Ewen, Lea Botermann, Dorothea Strauch, Dietmar Trenk et al. · 2018 · European Journal of Heart Failure
51. Expression of serum microRNA-155 and its clinical importance in patients with heart failure after myocardial infarction
    Baojian Zhang, Biao Li, Fen Qin, Fan Bai, Chao Sun, Qiming Liu · 2019 · Journal of International Medical Research
52. Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction
    Alison M. Brann, Satit Janwanishstaporn, Barry Greenberg · 2020 · JAMA Cardiology
53. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
    Marta Cobo Marcos, Rafael de la Espriella, Jara Gayán Ordás, Pau Llàcer, Antonia Pomares, Aleix Fort, Inés Ponz de Antonio, Ana Belén Méndez, Zorba Blázquez‐Bermejo, Pedro Caravaca Pérez et al. · 2023 · Revista Española de Cardiología (English Edition)
54. Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records
    Robert A Fletcher, Patrick Rockenschaub, Brendon Lange Neuen, Isabel Johanna Walter, Nathalie Conrad, Mehrdad A. Mizani, Thomas R Bolton, Claire Alexandra Lawson, Christopher Tomlinson, Stelios Boulitsakis Logothetis et al. · 2024 · The Lancet Public Health
55. Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
    Josefin Sundh, Hans Bornefalk, Carl Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk Hermansson, Helena Igelström, Magnus Per Ekström · 2019 · BMJ Open Respiratory Research
56. Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry
    Felix Lindberg, Lars H. Lund, Lina Benson, Ulf Dahlström, Patric Karlström, Cecilia Marianne Linde, Giuseppe M.C. Rosano, Gianluigi Savarese · 2022 · European Journal of Heart Failure
57. Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
    Panagiotis Theofilis, Evangelos K. Oikonomou, Konstantinos P Tsioufis, Dimitris Tousoulis · 2023 · Life
58. Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
    Marianna Adamo, Marco Metra, Brian Lee Claggett, Zi Michael Miao, Rafael Díaz, Gary Michael Felker, John J.V. McMurray, Scott David Solomon, Tor Biering‐Sørensen, Punag Divanji et al. · 2024 · JACC Heart Failure
59. Sacubitril–Valsartan in Heart Failure and Multimorbidity Patients
    Raquel Rodil Fraile, Vincenzo Malafarina, Gregorio Tiberio López · 2018 · ESC Heart Failure
60. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure
    Peter Ihle, Katrin Krueger, Ingrid Schübert, Nina Griese‐Mammen, Natalie Parrau, Ulrich Laufs, Martin Schulz · 2019 · Clinical Pharmacology & Therapeutics
61. Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia
    Jordi Real, Bogdan Vlacho, Emilio Ortega, Joan Antoni Vallés, Manel Mata‐Cases, Esmeralda Castelblanco, Eric T Wittbrodt, Peter Fenici, Mikhail Kosiborod, Dı́dac Mauricio et al. · 2021 · Cardiovascular Diabetology
62. Characteristics and outcome for heart failure patients with mid-range ejection fraction
    Nelson Wang, Susan Hales, Edward S. Barin, Geoffrey H. Tofler · 2018 · Journal of Cardiovascular Medicine
63. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis
    Д. А. Лебедев, E. A. Lyasnikova, Elena Yu. Vasilieva, Alina Yu. Babenko, Evgeny V. Shlyakhto · 2020 · Journal of Diabetes Research
64. Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
    Qing Zhou, Peixin Li, Hengli Zhao, Xingbo Xu, Shaoping Li, Jing Zhao, Dingli Xu, Qingchun Zeng · 2021 · Frontiers in Cardiovascular Medicine
65. Real-world implementation of guidelines for heart failure management: A systematic review and meta-analysis
    Grigorios Tsigkas, Anastasiοs Apostolos, Konstantinos A. Aznaouridis, Stefanos Despotopoulos, Christina A. Chrysohoou, Katerina Κ. Naka, Periklis A. Davlouros · 2022 · Hellenic Journal of Cardiology
66. Phenotyping in heart failure with preserved ejection fraction: A key to find effective treatment
    Magdalena Zawadzka, Marcin Grabowski, Agnieszka Kapłon‐Cieślicka · 2022 · Advances in Clinical and Experimental Medicine
67. Insights into the post-translational modifications in heart failure
    Xudong Zhang, Yan Wang, Huaping Li, Dao Wen Wang, Chen Chen · 2024 · Ageing Research Reviews
68. Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
    Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios T. Farmakis, Magdy Abdelhamid, Lars H Lund, Veli‐Pekka Harjola, Stefan D. Anker, Gerasimos Filippatos, Tuvia Ben Gal, Kevin Damman et al. · 2025 · European Journal of Heart Failure
69. Heart Failure in Patients Undergoing Elective and Emergency Noncardiac Surgery: Still a Poorly Addressed Risk Factor
    Ulrika Ljung Faxén, Linn Hallqvist, Lina Benson, Benedikt Schrage, Lars H. Lund, Max Bell · 2020 · Journal of Cardiac Failure
70. Resting Heart Rate as an Important Predictor of Mortality and Morbidity in Ambulatory Patients With Heart Failure: A Systematic Review and Meta-Analysis
    Kimberley Lau, Abdullah Malik, Farid Foroutan, Tayler A. Buchan, Julian F. Daza, Nigar Sekercioglu, Ani Orchanian‐Cheff, Ana Carolina Alba · 2020 · Journal of Cardiac Failure
71. Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification
    Luigi Pannone, Giulio Falasconi, Lorenzo Cianfanelli, Luca Baldetti, Francesco Moroni, Roberto Spoladore, Pasquale Vergara · 2021 · Journal of Clinical Medicine
72. 20 Years of Real-World Data to Estimate the Prevalence of Heart Failure and Its Subtypes in an Unselected Population of Integrated Care Units
    Cristina Gavina, Daniel Seabra, F Valente, Filipa Bernardo, Ricardo Jorge Dinis‐Oliveira, Carla Santos-Araújo, Tiago Taveira‐Gomes · 2022 · Journal of Cardiovascular Development and Disease
73. Association of Chronic Heart Failure with Frailty, Malnutrition, and Sarcopenia Parameters in Older Patients—A Cross-Sectional Study in a Geriatric Ward
    Miroslaw Charkiewicz, Zyta Beata Wojszel, Agnieszka Kasiukiewicz, Łukasz Magnuszewski, Aleksandra Wojszel · 2023 · Journal of Clinical Medicine
74. Prevalencia y perfil clínico de la enfermedad renal en pacientes con insuficiencia cardiaca crónica. Datos del Registro cardiorrenal español
    Marta Cobo Marcos, Rafael de la Espriella, Jara Gayán Ordás, Pau Llàcer, Antonia Pomares, Aleix Fort, Inés Ponz de Antonio, Ana Belén Méndez, Zorba Blázquez‐Bermejo, Pedro Caravaca Pérez et al. · 2023 · Revista Española de Cardiología
75. Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis
    Daniela Tomasoni, Alberto Aimo, Aldostefano Porcari, Giovanni Battista Bonfioli, Vincenzo Castiglione, Riccardo Saro, Mattia Di Pasquale, Maria Franzini, Iacopo Fabiani, Carlo Lombardi et al. · 2024 · European Heart Journal - Cardiovascular Imaging
76. The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction
    Matteo Beltrami, Alberto Palazzuoli, Luigi Padeletti, Elisabetta Cerbai, Stefano Coiro, Michele Emdin, Rossella Marcucci, Doralisa Morrone, Matteo Cameli, Ketty Savino et al. · 2017 · International Journal of Clinical Practice
77. Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
    Kevin Shah, James Chen-Tson Fang · 2019 · Current Hypertension Reports
78. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR)
    Masahiro Seo, Takahisa Yamada, Shunsuke Tamaki, Tetsuya Watanabe, Takashi Morita, Yoshio Furukawa, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Makoto Abe et al. · 2020 · European Heart Journal - Cardiovascular Imaging
79. Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
    Olga N. Dzhioeva, Evgeny Belyavskiy · 2020 · Therapeutics and Clinical Risk Management
80. Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
    Mohanad Alkhodari, Herbert Franz Jelinek, Angelos Karlas, Στέργιος Σουλαϊδόπουλος, Πέτρος Αρσένος, Ioannis Doundoulakis, Konstantinos A. Gatzoulis, Konstantinos P Tsioufis, Leontios J. Hadjileontiadis, Ahsan Habib Khandoker · 2021 · Frontiers in Cardiovascular Medicine
81. Heart Failure with Mid-Range Ejection Fraction - State of the Art
    Evandro Tinoco Mesquita, Letícia Mara dos Santos Barbetta, Eduardo Thadeu de Oliveira Correia · 2019 · Arquivos Brasileiros de Cardiologia
82. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction
    Yuxi Sun, Jinping Si, Jiaxin Li, Mengyuan Dai, Emma King, Xinxin Zhang, Yanli Zhang, Yunlong Xia, Gary Tse, Ying Liu · 2021 · Frontiers in Cardiovascular Medicine
83. Long-Term Mortality in Heart Failure with Mid-Range Ejection Fraction: Systematic Review and Meta-Analysis
    Deep Chandh Raja, Indira Samarawickrema, Souvik Kumar Das, Abhinav B. Mehta, Lukah Q. Tuan, Sanjiv Jain, Sanjay Dixit, Frank Marchlinski, Walter P. Abhayaratna, Prashanthan Sanders et al. · 2022 · ESC Heart Failure
84. Data-driven identification of heart failure disease states and progression pathways using electronic health records
    Tasha Nagamine, Brian M. Gillette, John Kahoun, Rolf Burghaus, Jörg Lippert, Mayur Saxena · 2022 · Scientific Reports
85. The controversial role of beta-blockers in heart failure with preserved ejection fraction
    Simon Wernhart, Μαρία Παπαθανασίου, Tienush Rassaf, Peter Luedike · 2023 · Pharmacology & Therapeutics
86. Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management
    Mauro Riccardi, Maja Čikeš, Marianna Adamo, Matteo Pagnesi, Carlo Lombardi, Scott David Solomon, Marco Metra, Riccardo Maria Inciardi · 2024 · Journal of Cardiac Failure
87. Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
    Anders Hovland, Liv J. Mundal, Jannicke Igland, Marit Bragelien Veierød, Kirsten Bjørklund Holven, Martin Prøven Bogsrud, Grethe Seppola Tell, Trond P. Leren, Kjetil Retterstøl · 2017 · Atherosclerosis
88. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus
    Fauchier, Laurent, Boriani, Giuseppe, de Groot, Joris R, Kreutz, Reinhold, Rossing, Peter, Camm, A John · 2021 · EP Europace
89. Exercise Training in Heart Failure: Current Evidence and Future Directions
    Loay Eleyan, Ahmed Reda Gonnah, Imran Farhad, Aser Labib, Alisha Varia, Alaa Eleyan, Abdullah Almehandi, Abdulrahman Al-Naseem, David Hesketh Roberts · 2025 · Journal of Clinical Medicine
90. Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF
    Evan M. Murray, Stephen John Greene, Vishal N. Rao, Jie‐Lena Sun, Brooke Alhanti, Vanessa L. Blumer, Javed Butler, Tariq Ahmad, Robert John Mentz · 2022 · American Heart Journal
91. The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial
    David Booth, Jason A. Davis, Phil C. McEwan, Scott David Solomon, John J.V. McMurray, Rudolf A. de Boer, Josep Comin Colet, Erasmus Bachus, Jieling Chen · 2023 · European Journal of Heart Failure
92. A Registry-Based Algorithm to Predict Ejection Fraction in Patients with Heart Failure
    Alicia Uijl, Lars H. Lund, Ilonca C. H. Vaartjes, Jasper Jan Brugts, Gerard C.M. Linssen, Folkert Wouter Asselbergs, Arno Wilhelmus Hoes, Ulf Dahlström, Stefan Koudstaal, Gianluigi Savarese · 2020 · ESC Heart Failure
93. Ejection fraction in heart failure revisited- where does the evidence start?
    Michael Böhm, Yvonne Bewarder, Ingrid Kindermann · 2020 · European Heart Journal
94. Trends in the Treatment and Survival of Heart Failure Patients: A Nationwide Population-Based Study in the Czech Republic
    Miloš Táborský, Tomáš Skála, Marie Lazárová, Renata Aiglová, Jindřich Špinar, Lenka Špinarová, Jiří Vítovec, Josef Kautzner, Vojtěch Melenovský, Filip Málek et al. · 2021 · ESC Heart Failure
95. D-Dimer and Outcomes in Hospitalized Heart Failure Patients Across the Ejection Fraction Phenotypes
    Liyan Huang, Lin Liang, Pengchao Tian, Lang Zhao, Yuyi Chen, Yan Huang, Qiong Zhou, Mei Zhai, Yuhui Zhang, Giuseppe Ambrosio et al. · 2022 · ESC Heart Failure
96. Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction
    Malin Christersson, Stefan Gustafsson, Erik Lampa, Matilda Almstedt, Thomas Cars, Johan Bodegård, Gabriel Arefalk, Johan Sundström · 2024 · Journal of the American Heart Association
97. Spironolactone Use is Associated with Improved Outcomes in Heart Failure with Mid-Range Ejection Fraction
    Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Taiki Higo, Miyuki Tsuchihashi‐Makaya, Hiroyuki Tsutsui · 2020 · ESC Heart Failure
98. Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series Analysis
    Domenico Acanfora, Pietro Scicchitano, Chiara Acanfora, Roberto Maestri, Fernando Goglia, Raffaele Antonelli Incalzi, Alessandro Santo Bortone, Marco Matteo Ciccone, Massimo Uguccioni, Gerardo Casucci · 2020 · Clinical Drug Investigation
99. Rehospitalization Burden and Morbidity Risk in Patients with Heart Failure with Mid-Range Ejection Fraction
    Enrique Santas, Rafael de la Espriella, Patricia Palau, Gema Miñana, Martina Amiguet, Juan Manuel Sanchís, Josep Lupón, Antoni Bayés‐Genís, F. Javier Chorro, Julio Núñez Villota · 2020 · ESC Heart Failure
100. Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry
     CHECK-HF investigators, Gerard C.M. Linssen, Jesse F. Veenis, Hans‐Peter Brunner‐La Rocca, Petra E.J. van Pol, Domien J Engelen, Rob van Tooren, Hetty J. J. Koornstra-Wortel, Arno Wilhelmus Hoes, Jasper Jan Brugts · 2020 · Netherlands Heart Journal